Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 42.1MCash and Equivalents
VS
Market
Sector
Industry
History
$ 1.77Close
$ 1.05 - $ 8.57 52-Week Range
Ticker Information
Ticker
ACRVCompany Name
ACRIVON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQACRIVON THERAPEUTICS INC - Cash and Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ACRV - CashnEq Historical data
| Date | Cash and Equivalents |
|---|---|
| 6/30/2025 | $ 42.1M |
| 3/31/2025 | $ 39.35M |
| 12/31/2024 | $ 40.02M |
| 9/30/2024 | $ 43.61M |
| 6/30/2024 | $ 46.43M |
| 3/31/2024 | $ 25.02M |
| 12/31/2023 | $ 36.43M |
| 9/30/2023 | $ 30.27M |
| 6/30/2023 | $ 38.48M |
| 3/31/2023 | $ 27.88M |
Key Performance Insights, Last 5 Years
- ACRIVON THERAPEUTICS INC's latest trailing twelve months (TTM) CashnEq stands at $ 99.99M.
- Over the past 5 years, ACRIVON THERAPEUTICS INC's average CashnEq has been $ 44.01M.
- The median CashnEq for ACRIVON THERAPEUTICS INC during this period was $ 38.92M
- ACRIVON THERAPEUTICS INC reached its highest CashnEq over the past 5 years at $ 99.99M.
- The lowest CashnEq recorded by ACRIVON THERAPEUTICS INC in the same timeframe $ 25.02M
Similar metrics to CashnEq:
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Non-Current Assets - [Balance Sheet] The non-current (long-term) portion of [Assets] that are not easily converted to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Cash and Equivalents
[Balance Sheet] Cash and cash equivalents are the sum of [Assets] that are cash or can be converted to cash in less than one year.ACRV - Cash and Equivalents, Last 5 years
$ 25.02M
Minimum
Mar 31, 2024
$ 99.99M
Maximum
Dec 31, 2021
$ 44.01M
Average
$ 38.92M
Median
CashnEq Benchmark AnalysisMarket
The chart above depicts the distribution of CashnEq for companies in the Total Stock Market. The average CashnEq of the companies is $ 99.38M with a standard deviation of $ 119.91M.
The following table provides additional summary stats:
CashnEq in the Market:
| filtered constituents | 3.61K |
|---|---|
| min | $ 0 |
| max | $ 495M |
| average | $ 99.38M |
| median | $ 48.47M |
| std | $ 119.91M |